GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/POEM for symptomatic blown-out myotomy

POEM for symptomatic blown-out myotomy

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated November 1, 2025

Quick Answer

Blown-out myotomy (BOM) is a structural complication that can occur after a previous myotomy for achalasia, a condition where the esophagus has difficulty moving food into the stomach. In BOM, the original myotomy (a surgical cut in the esophageal muscles to improve swallowing) fails or disrupts, leading to poor esophageal emptying and a recurrence of symptoms like difficulty swallowing, chest pain, or regurgitation.


Blown-out myotomy (BOM) is a structural complication that can occur after a previous myotomy for achalasia, a condition where the esophagus has difficulty moving food into the stomach. In BOM, the original myotomy (a surgical cut in the esophageal muscles to improve swallowing) fails or disrupts, leading to poor esophageal emptying and a recurrence of symptoms like difficulty swallowing, chest pain, or regurgitation. When these symptoms significantly impact a patient’s quality of life, it is referred to as symptomatic blown-out myotomy.

Peroral Endoscopic Myotomy (POEM) is a minimally invasive endoscopic procedure that is used as a salvage treatment for symptomatic BOM. During POEM, a flexible endoscope is inserted through the mouth to access the esophagus. The surgeon creates a tunnel in the esophageal lining and cuts the problematic muscle layers to restore proper esophageal function.

The study found that POEM is both safe and effective for treating symptomatic BOM. It had a low rate of complications, even in anatomically altered cases like BOM. Clinical success was high (85.7% at 2 years), meaning most patients experienced significant symptom relief. This makes POEM a reliable option for patients with recurrent achalasia symptoms due to BOM, helping them regain better swallowing and quality of life.

Related Q&A

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026

Introduction: Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events requiring reversal. This study describes a novel...

EUS Double Drainage for Malignant Dual Obstruction : Gut | Jul 2026

Introduction: Simultaneous malignant distal biliary obstruction (MDBO) and gastric outlet obstruction (GOO), commonly caused by advanced pancreatic, biliary, or duodenal cancers, presents a major palliative challenge. Conventional endoscopic approaches often require repeated interventions and may...

Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026

Introduction: Long benign esophageal strictures remain one of the most difficult benign conditions to manage. Although endoscopic dilation and incision techniques provide temporary relief, recurrence is common, often requiring repeated interventions. This study introduces a...

Economic Impact of POEM and ESD: GIE | June 2026

Introduction: Peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) have revolutionized the management of esophageal motility disorders and early gastrointestinal neoplasia. Despite their proven clinical benefits, widespread adoption has been limited by concerns regarding...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer